These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18303446)

  • 21. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
    Sun JM; Lee KW; Kim JH; Kim YJ; Yoon HI; Lee JH; Lee CT; Lee JS
    Jpn J Clin Oncol; 2009 Jan; 39(1):27-32. PubMed ID: 18952704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of a promising new agent--pemetrexed disodium.
    Paz-Ares L; Bezares S; Tabernero JM; Castellanos D; Cortes-Funes H
    Cancer; 2003 Apr; 97(8 Suppl):2056-63. PubMed ID: 12673697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer.
    Vootukuru V; Liew YP; Nally JV
    Med Oncol; 2006; 23(3):419-22. PubMed ID: 17018900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe rhabdomyolysis associated with pemetrexed-based chemotherapy.
    Ceribelli A; Cecere FL; Milella M; Facciolo F; Gelibter A; Cognetti F
    Lancet Oncol; 2006 Apr; 7(4):353. PubMed ID: 16574552
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2.
    Zukin M; Barrios CH; Pereira JR; Ribeiro Rde A; Beato CA; do Nascimento YN; Murad A; Franke FA; Precivale M; Araujo LH; Baldotto CS; Vieira FM; Small IA; Ferreira CG; Lilenbaum RC
    J Clin Oncol; 2013 Aug; 31(23):2849-53. PubMed ID: 23775961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pemetrexed-induced cellulitis: a rare toxicity in non-small cell lung cancer treatment.
    Katsenos S; Psara A; Panagou C
    J Oncol Pharm Pract; 2013 Mar; 19(1):93-4. PubMed ID: 22357637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute generalized exanthematous pustulosis-like drug eruption induced by pemetrexed.
    Hattori T; Tamura A; Ishikawa O
    Eur J Dermatol; 2011; 21(6):998-9. PubMed ID: 21896401
    [No Abstract]   [Full Text] [Related]  

  • 28. [Safety of pemetrexed according to the duration of vitamin B12 and folic acid supplementation prior to the first dose of pemetrexed].
    Tsuda Y; Kitamura A; Nishimura N; Yagi N; Takayama S; Okafuji K; Tomishima Y; Jinta T; Koyama K; Ohde S; Gotoh K; Chohnabayashi N
    Gan To Kagaku Ryoho; 2015 Apr; 42(4):471-5. PubMed ID: 25963695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of risk factors for adverse events due to pemetrexed in patients with reduced renal function].
    Kono M; Sakata Y; Sugawara T; Abe K; Miyamori S; Miura S; Hata Y; Funaki M; Inata J; Kanehara M; Hiraki K; Iwamoto Y
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2587-90. PubMed ID: 25596053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and fatal thrombocytopenic thrombotic purpura after a single dose of pemetrexed.
    Alabiso I; Baratelli C; Brizzi MP; Bitossi R; Ottone A; Tampellini M
    Int J Clin Pharm; 2014 Dec; 36(6):1141-3. PubMed ID: 25370901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pemetrexed-associated urticarial vasculitis.
    Lopes G; Vincek V; Raez LE
    Lung Cancer; 2006 Feb; 51(2):247-9. PubMed ID: 16360237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pemetrexed: new indication. Untreated non-small cell lung cancer: just another cytotoxic drug. No better than the gemcitabine-cisplatin combination with a different safety profile, as is the case for other cytotoxic drugs.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19637425
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pemetrexed nephrotoxicity].
    Izzedine H
    Bull Cancer; 2015 Feb; 102(2):190-7. PubMed ID: 25641712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of Pemetrexed Monotherapy in Advanced Non-Small Cell Lung Cancer Patients with Impaired Renal Function].
    Funaguchi N; Nakajima Y; Kaito D; Yanase K; Ito F; Endo J; Morishita M; Asano M; Iihara H; Mori H; Ohno Y; Minatoguchi S
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):705-8. PubMed ID: 26199241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The efficacy and safety of pemetrexed as monotherapy for Chinese patients with advanced non-small cell lung cancer].
    Zhong W; Zhao J; Zhang XT; Zhang L; Wang MZ; Li LY
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):671-4. PubMed ID: 20979786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer].
    Tummino C; Barlesi F; Tchouhadjian C; Tasei AM; Gaudy-Marqueste C; Richard MA; Astoul P
    Rev Mal Respir; 2007 May; 24(5):635-8. PubMed ID: 17519817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Safety and effectiveness of pemetrexed in patients with non-small cell lung cancer in Japan - analysis of post-marketing surveillance].
    Okubo S; Kobayashi N; Taketsuna M; Kaneko N; Enatsu S; Nishiuma S
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):475-81. PubMed ID: 24743364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001).
    Hattori Y; Satouchi M; Katakami N; Fujita S; Kaji R; Hata A; Urata Y; Shimada T; Uchida J; Tomii K; Morita S; Negoro S
    Cancer Chemother Pharmacol; 2014 Jan; 73(1):17-23. PubMed ID: 24141372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemetrexed in first-line treatment of non-small cell lung cancer.
    Esteban E; Casillas M; Cassinello A
    Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pemetrexed-induced anaphylaxis.
    Shah BK; Hewett Y
    Acta Oncol; 2013 May; 52(4):881. PubMed ID: 23472834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.